We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KHC icon
801
Kraft Heinz
KHC
$29.3B
$251K 0.02%
+8,243
New +$247K
SIL icon
802
Global X Silver Miners ETF NEW
SIL
$4.84B
$251K 0.02%
+6,354
New +$228K
AKBA icon
803
Akebia Therapeutics
AKBA
$242M
$250K 0.02%
130,288
+37,137
+40% +$75.8K
UI icon
804
Ubiquiti
UI
$34.6B
$250K 0.02%
+806
New +$285K
WBA
805
DELISTED
Walgreens Boots Alliance
WBA
$249K 0.02%
+22,302
New +$242K
AIOT
806
PowerFleet Inc
AIOT
$400M
$249K 0.02%
45,371
+12,585
+38% +$80.7K
CNXC icon
807
Concentrix
CNXC
$1.57B
$249K 0.02%
+4,473
New +$214K
MOD icon
808
Modine Manufacturing
MOD
$10.6B
$249K 0.02%
+3,241
New +$319K
TRMB icon
809
Trimble
TRMB
$13.6B
$247K 0.02%
+3,761
New +$270K
LHX icon
810
L3Harris
LHX
$53.4B
$247K 0.02%
1,179
-9
-0.8% -$1.89K
MEOH icon
811
Methanex
MEOH
$4.28B
$247K 0.02%
+7,028
New +$316K
FBP icon
812
First Bancorp
FBP
$4.43B
$245K 0.02%
12,797
+1,866
+17% +$36.2K
HCI icon
813
HCI Group
HCI
$2.28B
$245K 0.02%
+1,640
New +$208K
AXS icon
814
AXIS Capital
AXS
$7.39B
$243K 0.02%
+2,426
New +$224K
THRD
815
DELISTED
Third Harmonic Bio
THRD
$243K 0.02%
+69,900
New +$339K
APG icon
816
APi Group
APG
$18.6B
$242K 0.02%
+10,172
New +$255K
ESPR
817
DELISTED
Esperion Therapeutics
ESPR
$242K 0.02%
168,305
+48,630
+41% +$89.6K
MDT icon
818
Medtronic
MDT
$115B
$241K 0.02%
2,681
-656
-20% -$58.7K
PRKS icon
819
United Parks & Resorts
PRKS
$2B
$240K 0.02%
5,284
-2,211
-29% -$114K
FFBC icon
820
First Financial Bancorp
FFBC
$3.56B
$240K 0.02%
+9,593
New +$256K
EXEL icon
821
Exelixis
EXEL
$13B
$238K 0.02%
+6,436
New +$229K
MET icon
822
MetLife
MET
$61.5B
$238K 0.02%
+2,959
New +$246K
CMI icon
823
Cummins
CMI
$87.9B
$237K 0.02%
756
-700
-48% -$247K
AVO icon
824
Mission Produce
AVO
$1.15B
$237K 0.02%
22,600
+11,000
+95% +$128K
AS icon
825
Amer Sports
AS
$19.9B
$236K 0.02%
8,828
-9,772
-53% -$289K
31 32
33
34 35

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.